Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2056-9920
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors ; volume:7 ; number:1 ; day:11 ; month:1 ; year:2021 ; pages:1-8 ; date:12.2021
International Journal of Retina and Vitreous ; 7, Heft 1 (11.1.2021), 1-8, 12.2021
- Creator
-
Bazvand, Fatemeh
Riazi-Esfahani, Hamid
Mirshahi, Ahmad
Khodabande, Alireza
Khojastheh, Hasan
Farahani, Afsar Dastjani
Roohipourmoallai, Ramak
Imani, Marjan
Faghihi, Hooshang
Adib, Nazanin Ebrahimi
Bahar, Mohammadreza Mehrabi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40942-020-00276-3
- URN
-
urn:nbn:de:101:1-2021030222585206041556
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bazvand, Fatemeh
- Riazi-Esfahani, Hamid
- Mirshahi, Ahmad
- Khodabande, Alireza
- Khojastheh, Hasan
- Farahani, Afsar Dastjani
- Roohipourmoallai, Ramak
- Imani, Marjan
- Faghihi, Hooshang
- Adib, Nazanin Ebrahimi
- Bahar, Mohammadreza Mehrabi
- SpringerLink (Online service)
Other Objects (12)
Evaluating the causes of retinopathy of prematurity relapse following intravitreal bevacizumab injection
Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity
Ocular phenotype and genetical analysis in patients with retinopathy of prematurity
Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity
Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab
Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis
Evaluating the causes of retinopathy of prematurity relapse following intravitreal bevacizumab injection
Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity
Ocular phenotype and genetical analysis in patients with retinopathy of prematurity
Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity
Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab
Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis
Evaluating the causes of retinopathy of prematurity relapse following intravitreal bevacizumab injection
Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity
Ocular phenotype and genetical analysis in patients with retinopathy of prematurity
Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity
Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab
Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity